Compare EPSN & FOCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EPSN | FOCL |
|---|---|---|
| Founded | 2005 | 1979 |
| Country | United States | France |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 187.2M | 206.3M |
| IPO Year | 2018 | 1998 |
| Metric | EPSN | FOCL |
|---|---|---|
| Price | $4.96 | $2.82 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $8.30 |
| AVG Volume (30 Days) | 62.5K | ★ 63.1K |
| Earning Date | 11-23-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.26 | N/A |
| Revenue | N/A | ★ $70,527,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $33.55 |
| P/E Ratio | $19.92 | ★ N/A |
| Revenue Growth | N/A | ★ 1.63 |
| 52 Week Low | $4.20 | $2.80 |
| 52 Week High | $6.65 | $6.40 |
| Indicator | EPSN | FOCL |
|---|---|---|
| Relative Strength Index (RSI) | 27.46 | 31.21 |
| Support Level | N/A | N/A |
| Resistance Level | $5.12 | $4.56 |
| Average True Range (ATR) | 0.28 | 0.35 |
| MACD | -0.05 | -0.09 |
| Stochastic Oscillator | 2.76 | 3.56 |
Epsilon Energy Ltd is a North American on-shore focused independent natural gas and oil company engaged in the acquisition, development, gathering and production of natural gas and oil reserves. Its properties include Appalachian Basin-Pennsylvania, Permian Basin-Texas and New Mexico, Anadarko Basin-Oklahoma, Powder River Basin-Wyoming, Western Canadian Sedimentary Basin-Alberta, Canada. Its segments include The Upstream segment activities include acquisition, development and production of natural gas and oil reserves on properties within the United States and Canada; and The Gas Gathering segment partners with two other companies to operate a natural gas gathering system. The Upstream segment derives the majority of the revenue.
Edap TMS SA, formerly known as FocalTherics, operates in the Robotic Focal Therapy industry. It develops, manufactures, and markets minimally invasive medical devices across various countries to treat various conditions using proprietary focused ultrasound technology. The company's flagship platform, Focal One Robotic HIFU, combines imaging, real-time treatment planning, robotic precision, and high intensity focused ultrasound (HIFU) technology. It is focused on expanding the clinical adoption of its patented focused ultrasound-based robotic therapy platforms through continued innovation, clinical evidence generation, physician education, and various market development initiatives.